Mucocutaneous toxicity induced by pegylated liposomal doxorubicin: a single-institution, retrospective case series.
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
M
M
Vaccaro
Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy.
M
M
Santarpia
Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
G
G
Calapai
Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
C
C
Mannucci
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
F
F
Borgia
Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy.
G
G
Altavilla
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
S P
SP
Cannavò
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies
D000903:Antibiotics, Antineoplastic; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin